Abiopharma

(90% Positive) KRYSTAL BIOTECH, INC. (KRYS) Announces Enrollment Update for revenue Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - David Toh

(19% Negative) BIOCRYST PHARMACEUTICALS INC (BCRX) Announces Delay in angioedema Trials for hereditary angioedema (HAE) in Europe Due to Regulatory Process

Financial Statements and Related Announcement: First Quarter Results

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Chen Peng

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Caecilia Chu

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011860 <b>Size:</b> 917 KB

(75% Positive) ADMA BIOLOGICS, INC. (ADMA) Provides Update on required for ASCENIV™

(30% Negative) COGENT COMMUNICATIONS HOLDINGS, INC. (CCOI) Reports Q2 2026 Financial Results

(50% Neutral) CNS PHARMACEUTICALS, INC. (CNSP) Announces Business Combination